Heartflow, Inc. Common Stock

HTFLNASDAQHealthcare● Active

$28.58

+$0.48(+1.71%)

Market Cap$2.5B

P/E Ratio—

52W High$41.223

52W Low$20.13

Avg Volume1.3M

Open$28.71

Beta1.91

Insider Trades Ownership Employees

Heartflow, Inc. Common Stock（HTFL）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · HTFL · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.06

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 6%仅显示有效交易 · 排除RSU归属94% Sell ↓

Heartflow, Inc. Common Stock内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

HTFL 季度内部人买卖趋势

HTFL 内幕交易卖出 · HTFL 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

7.0M3.5M0

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · HTFL CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

HTFL 高管卖出股份 · HTFL 董事内幕交易 · SEC Form 4申报

显示最近 41 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 18, 2026	Rogers Campbell Chief Medical Officer	Option	9,219	$19.00	$175K	87,950	Form 4
May 18, 2026	Rogers Campbell Chief Medical Officer	Sale	9,219	$28.34	$261K	78,731	Form 4
May 11, 2026	Farquhar John C.M. CEO · Director	Sale	22,562	$29.12	$657K	519,397	Form 4
May 6, 2026	Rogers Campbell Chief Medical Officer	Other	1,634	$30.29	$49K	79,368	Form 4
May 7, 2026	Rogers Campbell Chief Medical Officer	Other	637	$29.98	$19K	78,731	Form 4
May 6, 2026	Farquhar John C.M. CEO · Director	Other	5,300	$30.29	$161K	543,863	Form 4
May 7, 2026	Farquhar John C.M. CEO · Director	Other	1,904	$29.98	$57K	541,959	Form 4
Apr 28, 2026	Bain Capital Life Sciences Investors, LLC 10 percent owner	Sale	254,110	$30.51	$7.75M⚡	10,194,048	Form 4
Apr 29, 2026	Bain Capital Life Sciences Investors, LLC 10 percent owner	Sale	797,133	$29.37	$23.41M⚡	9,396,915	Form 4
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC 10 percent owner	Sale	892,533	$29.18	$26.04M⚡	8,504,382	Form 4
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC 10 percent owner	Sale	56,224	$30.05	$1.69M⚡	8,448,158	Form 4
Apr 10, 2026	Farquhar John C.M. CEO · Director	Sale	22,562	$26.72	$603K	549,163	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Option	6,849	$2.22	$15K	145,535	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Option	40,766	$2.22	$91K	138,686	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Option	19,111	$2.22	$42K	97,920	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Sale	64,533	$24.64	$1.59M⚡	81,002	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Option	291	$8.33	$2K	78,809	Form 4
Mar 24, 2026	Lightcap Jeffrey C Director	Other	206,261	—	—	246,261	Form 4
Mar 19, 2026	Rogers Campbell Chief Medical Officer	Option	47,615	$2.22	$106K	143,051	Form 4
Mar 19, 2026	Rogers Campbell Chief Medical Officer	Option	19,402	$2.22	$43K	95,436	Form 4
Mar 19, 2026	Rogers Campbell Chief Medical Officer	Sale	64,533	$25.69	$1.66M⚡	78,518	Form 4
Mar 18, 2026	Farquhar John C.M. CEO · Director	Sale	9,725	$25.00	$243K	571,725	Form 4
Mar 11, 2026	BARABE TIMOTHY C Director	Option	8,667	$2.22	$19K	179,521	Form 4
Mar 6, 2026	Farquhar John C.M. CEO · Director	Award	2,631	$16.15	$42K	594,287	Form 4
Mar 10, 2026	Farquhar John C.M. CEO · Director	Sale	12,837	$22.66	$291K	581,450	Form 4

Rogers Campbell

Chief Medical Officer

Option

日期

May 18

股数

9,219

均价

$19.00

总金额

$175K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Sale

日期

May 18

股数

9,219

均价

$28.34

总金额

$261K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Sale

日期

May 11

股数

22,562

均价

$29.12

总金额

$657K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Other

日期

May 6

股数

1,634

均价

$30.29

总金额

$49K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Other

日期

May 7

股数

637

均价

$29.98

总金额

$19K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Other

日期

May 6

股数

5,300

均价

$30.29

总金额

$161K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Other

日期

May 7

股数

1,904

均价

$29.98

总金额

$57K

View Form 4 on SEC.gov

Bain Capital Life Sciences Investors, LLC

10 percent owner

Sale

日期

Apr 28

股数

254,110

均价

$30.51

总金额

$7.75M ⚡

View Form 4 on SEC.gov

Bain Capital Life Sciences Investors, LLC

10 percent owner

Sale

日期

Apr 29

股数

797,133

均价

$29.37

总金额

$23.41M ⚡

View Form 4 on SEC.gov

Bain Capital Life Sciences Investors, LLC

10 percent owner

Sale

日期

Apr 30

股数

892,533

均价

$29.18

总金额

$26.04M ⚡

View Form 4 on SEC.gov

Bain Capital Life Sciences Investors, LLC

10 percent owner

Sale

日期

Apr 30

股数

56,224

均价

$30.05

总金额

$1.69M ⚡

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Sale

日期

Apr 10

股数

22,562

均价

$26.72

总金额

$603K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

日期

Apr 1

股数

6,849

均价

$2.22

总金额

$15K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

日期

Apr 1

股数

40,766

均价

$2.22

总金额

$91K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

日期

Apr 1

股数

19,111

均价

$2.22

总金额

$42K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Sale

日期

Apr 1

股数

64,533

均价

$24.64

总金额

$1.59M ⚡

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

日期

Apr 1

股数

291

均价

$8.33

总金额

$2K

View Form 4 on SEC.gov

Lightcap Jeffrey C

Director

Other

日期

Mar 24

股数

206,261

均价

—

总金额

—

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

日期

Mar 19

股数

47,615

均价

$2.22

总金额

$106K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

日期

Mar 19

股数

19,402

均价

$2.22

总金额

$43K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Sale

日期

Mar 19

股数

64,533

均价

$25.69

总金额

$1.66M ⚡

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Sale

日期

Mar 18

股数

9,725

均价

$25.00

总金额

$243K

View Form 4 on SEC.gov

BARABE TIMOTHY C

Director

Option

日期

Mar 11

股数

8,667

均价

$2.22

总金额

$19K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Award

日期

Mar 6

股数

2,631

均价

$16.15

总金额

$42K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Sale

日期

Mar 10

股数

12,837

均价

$22.66

总金额

$291K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 HTFL 内幕交易

HTFL 内幕交易

Heartflow, Inc. Common Stock（HTFL）内幕交易数据来源于公司内部人（包括Rogers Campbell (Chief Medical Officer), Farquhar John C.M. (CEO · Director), Bain Capital Life Sciences Investors, LLC (10 percent owner)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。HTFL内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Heartflow, Inc. Common Stock机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

HTFL 内幕交易 · 5个问题

Heartflow, Inc. Common Stock（HTFL）的内部人包括高管和董事，如Rogers Campbell (Chief Medical Officer), Farquhar John C.M. (CEO · Director), Bain Capital Life Sciences Investors, LLC (10 percent owner)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

HTFL 董事内幕交易HTFL 内部人名单Heartflow, Inc. Common Stock 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026